Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature

• Main Authors: Khalid Al Sulaiman SCC-CCP, BCCCP, BCNSP, MBA (Author), Awatif Hafiz PharmD, BCCP (Author), Hisham A. Badreldin PharmD, FCCP, BCPS, BCCP (Author), Ghazwa B. Korayem PharmD, BCPS (Author), Faisal Alsuwayyid PharmD (Author), Abdulrahman Alrashidi, PharmD (Author), Mohammed Alhijris PharmD (Author), Faisal Almutairi, PharmD (Author), Fahad Alharthi PharmD (Author), Saad Alghamdi PharmD (Author), Ahmed Abu Alreesh ClinPharmM.Sc (Author), Ohoud Aljuhani PharmD, BCCCP (Author)
• Format: Book
• Published: SAGE Publishing, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Several guidelines endorsed the indefinite use warfarin or heparin-containing products for acute venous thromboembolism (VTE) treatment and secondary prevention and discouraged the use of direct oral anticoagulants (DOAC) for patients diagnosed with antiphospholipid syndrome (APS). However, adequate...